Equity Research Report: FDC Limited Date: February 7, 2026 Analyst: Gemini (Stock Analysis AI) Current Market Price (CMP): ₹368 – ₹375 (Approx) 1️⃣ Business Model & Work 2️⃣ Industry & Sector Analysis 3️⃣ Latest Financial Performance (Q3 FY26 – Dec 2025) ⚠️ Data Source: Based on latest results announced Feb 5, 2026. Metric Q3 FY26 … Read more
Equity Research Report: Marksans Pharma Ltd. Date: February 7, 2026 Current Market Price (CMP): ₹177.15 (NSE Closing, Feb 6) Market Cap: ~₹8,037 Cr Sector: Pharmaceuticals (Formulations – OTC & Rx) 1️⃣ Business Model & Work 2️⃣ Industry & Sector Analysis 3️⃣ Latest Financial Performance (Consolidated) Latest Results (Q3 FY26 – Dec 2025): Company ne Q3 … Read more
Equity Research Report: Emcure Pharmaceuticals Ltd. Date: February 4, 2026 Current Market Price (CMP): ₹1,532 (Approx) Market Cap: ₹28,969 Cr (Mid Cap) Sector: Pharmaceuticals (Domestic & Exports) 1️⃣ Business Model & Work (Company Kya Karti Hai?) Emcure Pharmaceuticals ek research-driven pharma company hai jo India ki leading firms me se ek hai. Iska business model … Read more
Namaste! Ek professional Equity Research Analyst ke taur par, main Morepen Laboratories Limited (MOREPENLAB) ka deep fundamental analysis prastut kar raha hoon. Yeh report strictly latest available verified data (Screener.in, Yahoo Finance, aur Official Filings) par aadharit hai as of February 4, 2026. ⚠️ Note on Data: Latest available confirmed quarterly results Q2 FY26 (September … Read more
Professional Equity Research Report: Gland Pharma Limited (GLAND) Date: January 28, 2026 Analyst Role: Equity Research Analyst Sources: Screener.in, BSE Filings (Q3 FY26 Results declared today), Investor Presentations. Executive Summary Gland Pharma India ki ek unique pharmaceutical company hai jo B2B (Business-to-Business) model par kaam karti hai. Unlike Sun Pharma or Cipla, ye apni branding … Read more